Special milk powder aimed to help sick infants – but study never started

NCT ID NCT05922332

Terminated Disease control Sponsor: Children's Hospital of Fudan University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study planned to test whether a milk powder rich in medium-chain fatty acids could improve nutrition and health in infants with cholestatic liver disease. Researchers aimed to compare the special formula to regular milk powder in 64 infants under 6 months old. However, the study was withdrawn before any participants were enrolled, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: medium-chain fatty acid rich milk powder
What this could lead to: If it had worked, this could point toward a special diet to help infants with cholestatic liver disease gain weight and improve health.
What could go wrong: The study was withdrawn before enrolling any participants, so no data exist. Even if conducted, it was small (64 infants) and only tested a dietary supplement, not a cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHOLESTATIC LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cholestasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHOLESTATIC LIVER DISEASE

Contacts and locations

Locations

zhaoyang Gou

Shanghai, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.